ISRCTN31374767已完成不适用
A randomised prospective phase III comparison of paclitaxel - carboplatin versus docetaxel - carboplatin as first line chemotherapy in stage Ic-IV epithelial ovarian cancer
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Histologically confirmed epithelial ovarian cancer
- •3. At least 18 years old
- •4. Stage Ic-IV disease
- •5. Written informed consent
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
3 期
A phase III, prospective randomised comparison of imatinib (STI571, Glivec/Gleevec) 400 mg daily versus imatinib 800 mg daily versus imatinib plus PEG interferon-alpha 2a (Pegasys) in patients with newly-diagnosed chronic phasechronic myeloid leukaemiaChronic Myeloid LeukaemiaCancerISRCTN59346371ewcastle upon Tyne Hospitals Trust (UK)2,466
尚未招募
3 期
Altered breathing with postoperative pain reliefRespiratory DepressionPostoperative analgesiaDiet and Nutrition - ObesityRespiratory - Pain managementObesityACTRN12607000208404Royal Melbourne Hospital70
进行中（未招募）
1 期
Phase 3 Study of Pembrolizumab/Epacadostat/Chemotherapy in Metastatic NSCLCFirst-line treatment of metastatic NSCLCMedDRA version: 20.0Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-001810-27-FRIncyte Corporation233
进行中（未招募）
1 期
Phase 3 Study of Pembrolizumab/Epacadostat/Chemotherapy in Metastatic NSCLCFirst-line treatment of metastatic NSCLCMedDRA version: 20.0Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-001810-27-DEIncyte Corporation1,062
进行中（未招募）
1 期
Phase 3 Study of Pembrolizumab/Epacadostat/Chemotherapy in Metastatic NSCLCFirst-line treatment of metastatic NSCLCMedDRA version: 20.0Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-001810-27-ESIncyte Corporation233